FDA Inspection 1017139 — Advance Pharmaceutical Inc

Advance Pharmaceutical Inc — FEI 2434807

The FDA completed an inspection of Advance Pharmaceutical Inc on July 6, 2017 in Holtsville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 6, 2017
Fiscal Year
2017
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Holtsville, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
201721 CFR 211.188(b)(5)In-Process and Laboratory Control Results
240121 CFR 211.194(a)(4)Complete Test Data
358821 CFR 211.110(a)(3)Mixing adequacy
360321 CFR 211.160(b)Scientifically sound laboratory controls